Response assessment using (68)Ga-PSMA ligand PET in patients undergoing (177)Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer - Grubmuller, B; Senn, D; Kramer, G (Eur J Nucl Med Mol Imaging, 2019)
et al.